{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:00:57Z","timestamp":1792692057635,"version":"4.5.0"},"reference-count":105,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/pap.0b013e31826663b1","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T07:07:10Z","timestamp":1344582430000},"page":"296-312","source":"Crossref","is-referenced-by-count":42,"title":["Clear Cell Carcinoma of the Female Genital Tract (Not Everything Is as Clear as it Seems)"],"prefix":"10.1097","volume":"19","author":[{"given":"Saul L.","family":"Offman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri A.","family":"Longacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2008.02.006","article-title":"Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types A study of 1411 clear cell ovarian cancers.","volume":"109","author":"Chan","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/PGP.0b013e3181c042b6","article-title":"Differences in tumor type in low-stage versus high-stage ovarian carcinomas.","volume":"29","author":"Kobel","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin.","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5","article-title":"Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.","volume":"88","author":"Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1349-7006.2008.00747.x","article-title":"Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma.","volume":"99","author":"Itamochi","year":"2008","journal-title":"Cancer Sci"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/gyno.1996.0065","article-title":"Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease.","volume":"60","author":"Goff","year":"1996","journal-title":"Gynecol Oncol"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ygyno.2006.08.026","article-title":"Thromboembolic complications in patients with clear cell carcinoma of the ovary.","volume":"104","author":"Matsuura","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2009.10.069","article-title":"When never-events occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.","volume":"116","author":"Duska","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R9-2-20210202","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000226209","article-title":"Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review.","volume":"32","author":"Savvari","year":"2009","journal-title":"Onkologie"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PAS.0b013e31816380c4","article-title":"Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.","volume":"32","author":"Jensen","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","article-title":"Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2559.1997.d01-592.x","article-title":"Ovarian atypical endometriosis: its close association with malignant epithelial tumours.","volume":"30","author":"Fukunaga","year":"1997","journal-title":"Histopathology"},{"key":"R13-2-20210202","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/gyno.2000.5765","article-title":"Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study.","volume":"77","author":"Ogawa","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2011.10.001","article-title":"The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.","volume":"124","author":"Munksgaard","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2011.08.036","article-title":"Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.","volume":"123","author":"Higashi","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R16-2-20210202","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/PAS.0b013e31819c4271","article-title":"Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.","volume":"33","author":"Veras","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/PAS.0b013e31824b6eed","article-title":"Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.","volume":"36","author":"Cuff","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/gyno.2001.6382","article-title":"Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.","volume":"83","author":"Erzen","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/gyno.1998.5284","article-title":"Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation.","volume":"72","author":"Komiyama","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R20-2-20210202","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2008.05.025","article-title":"Prognostic implication of endometriosis in clear cell carcinoma of the ovary.","volume":"110","author":"Orezzoli","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R21-2-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2005.12.038","article-title":"Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.","volume":"102","author":"Pectasides","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2006.12.024","article-title":"Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary.","volume":"105","author":"Crotzer","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjc.6603116","article-title":"Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.","volume":"94","author":"Takano","year":"2006","journal-title":"Br J Cancer"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2011.01.005","article-title":"Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.","volume":"121","author":"Anglesio","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/PGP.0b013e31816b5cff","article-title":"Intraoperative assessment of clear cell carcinoma of the ovary.","volume":"27","author":"Stewart","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R26-2-20210202","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/PAS.0b013e318164edf7","article-title":"Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.","volume":"32","author":"Han","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R27-2-20210202","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/1097-0142(19851215)56:12<2922::AID-CNCR2820561233>3.0.CO;2-L","article-title":"Benign and borderline clear cell adenofibromas of the ovary.","volume":"56","author":"Bell","year":"1985","journal-title":"Cancer"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00004347-200107000-00008","article-title":"Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract.","volume":"20","author":"Vang","year":"2001","journal-title":"Int J Gynecol Pathol"},{"key":"R29-2-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semdp.2005.11.002","article-title":"Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.","volume":"22","author":"McCluggage","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"R30-2-20210202","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.PGP.0000071044.12278.43","article-title":"A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.","volume":"22","author":"Cameron","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/PAS.0b013e31815a565a","article-title":"Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.","volume":"32","author":"Esheba","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R32-2-20210202","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/PAS.0b013e318198177d","article-title":"SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.","volume":"33","author":"Cao","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R33-2-20210202","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/01.pas.0000138179.87957.32","article-title":"The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.","volume":"28","author":"Ramalingam","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R34-2-20210202","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e3181788546","article-title":"A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.","volume":"33","author":"Kobel","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R36-2-20210202","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/modpathol.3800492","article-title":"Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.","volume":"19","author":"Kato","year":"2006","journal-title":"Mod Pathol"},{"key":"R37-2-20210202","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.humpath.2006.12.018","article-title":"Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium.","volume":"38","author":"Yamamoto","year":"2007","journal-title":"Hum Pathol"},{"key":"R38-2-20210202","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0002-9440(10)63605-X","article-title":"Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.","volume":"163","author":"Tsuchiya","year":"2003","journal-title":"Am J Pathol"},{"key":"R39-2-20210202","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004347-200404000-00004","article-title":"WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium.","volume":"23","author":"Acs","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R40-2-20210202","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.","volume":"5","author":"Kobel","year":"2008","journal-title":"PLoS Med"},{"key":"R41-2-20210202","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R42-2-20210202","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/PAS.0b013e31822d787c","article-title":"PAX2 and PAX8 expression in primary and metastatic mullerian epithelial tumors: a comprehensive comparison.","volume":"35","author":"Ozcan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R43-2-20210202","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors.","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R44-2-20210202","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1309\/AJCPU0FION3RKKFO","article-title":"Value of PAX8 and WT1 immunostaining in confirming the ovarian origin of metastatic carcinoma in serous effusion specimens.","volume":"137","author":"Zhao","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R45-2-20210202","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/IGC.0b013e3181a19eca","article-title":"The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary.","volume":"19","author":"Kobayashi","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R46-2-20210202","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.pas.0000135528.03942.1f","article-title":"OCT4: a novel biomarker for dysgerminoma of the ovary.","volume":"28","author":"Cheng","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R47-2-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.","volume":"221","author":"Ahmed","year":"2010","journal-title":"J Pathol"},{"key":"R48-2-20210202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-8-17","article-title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.","volume":"8","author":"Press","year":"2008","journal-title":"BMC Cancer"},{"key":"R50-2-20210202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma.","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"R51-2-20210202","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas.","volume":"363","author":"Wiegand","year":"2010","journal-title":"N Engl J Med"},{"key":"R52-2-20210202","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/modpathol.2011.189","article-title":"Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.","volume":"25","author":"Yamamoto","year":"2012","journal-title":"Mod Pathol"},{"key":"R53-2-20210202","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2353\/ajpath.2009.081000","article-title":"Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.","volume":"174","author":"Kuo","year":"2009","journal-title":"Am J Pathol"},{"key":"R54-2-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/path.2940","article-title":"PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.","volume":"225","author":"Yamamoto","year":"2011","journal-title":"J Pathol"},{"key":"R55-2-20210202","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ygyno.2005.09.047","article-title":"PTEN expression in clear cell adenocarcinoma of the ovary.","volume":"101","author":"Hashiguchi","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R56-2-20210202","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/path.2911","article-title":"Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas.","volume":"224","author":"Wiegand","year":"2011","journal-title":"J Pathol"},{"key":"R57-2-20210202","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.humpath.2008.01.003","article-title":"Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.","volume":"39","author":"Gilks","year":"2008","journal-title":"Hum Pathol"},{"key":"R58-2-20210202","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/PAS.0b013e31814fa9b0","article-title":"Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.","volume":"32","author":"Sangoi","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R59-2-20210202","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.humpath.2009.01.002","article-title":"Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms.","volume":"40","author":"Ohishi","year":"2009","journal-title":"Hum Pathol"},{"key":"R60-2-20210202","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/PAS.0b013e3180339ed7","article-title":"Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.","volume":"31","author":"Silva","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R61-2-20210202","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0046-8177(98)80002-6","article-title":"Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.","volume":"29","author":"Lax","year":"1998","journal-title":"Hum Pathol"},{"key":"R62-2-20210202","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/modpathol.3800620","article-title":"Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.","volume":"19","author":"Reid-Nicholson","year":"2006","journal-title":"Mod Pathol"},{"key":"R63-2-20210202","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1525-1438.2006.00494.x","article-title":"Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma.","volume":"16","author":"Arai","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R65-2-20210202","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/01.pas.0000155160.36154.mL","article-title":"Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma.","volume":"29","author":"Aydin","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R66-2-20210202","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/gyno.1999.5505","article-title":"Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.","volume":"74","author":"Cirisano","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R67-2-20210202","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO;2-Y","article-title":"Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern.","volume":"78","author":"Abeler","year":"1996","journal-title":"Cancer"},{"key":"R68-2-20210202","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/1097-0142(197305)31:5<1127::AID-CNCR2820310514>3.0.CO;2-E","article-title":"Clear cell carcinoma of the endometrium. Clinical, pathologic, and ultrastructural findings.","volume":"31","author":"Silverberg","year":"1973","journal-title":"Cancer"},{"key":"R69-2-20210202","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers.","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br J Cancer"},{"key":"R70-2-20210202","first-page":"228","article-title":"A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.","volume":"81","author":"Lax","year":"1997","journal-title":"Verh Dtsch Ges Pathol"},{"key":"R71-2-20210202","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/1097-0142(19820415)49:8<1511::AID-CNCR2820490802>3.0.CO;2-6","article-title":"Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma.","volume":"49","author":"Christopherson","year":"1982","journal-title":"Cancer"},{"key":"R72-2-20210202","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0090-8258(90)90279-T","article-title":"Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases.","volume":"40","author":"Abeler","year":"1991","journal-title":"Gynecol Oncol"},{"key":"R73-2-20210202","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10552-010-9526-5","article-title":"Cancer risk in DES daughters.","volume":"21","author":"Verloop","year":"2010","journal-title":"Cancer Causes Control"},{"key":"R74-2-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-199501000-00003","article-title":"Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving antiestrogens (tamoxifen) and gestagens.","volume":"14","author":"Dallenbach-Hellweg","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"R75-2-20210202","first-page":"1327","article-title":"Clear cell carcinoma of the endometrium: a biological and clinical enigma.","volume":"30","author":"Gadducci","year":"2010","journal-title":"Anticancer Res"},{"key":"R76-2-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2007.04.032","article-title":"The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.","volume":"106","author":"McMeekin","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R77-2-20210202","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/pgmj.69.814.640","article-title":"Parathyroid hormone-related protein as a tumour marker in humoral hypercalcaemia associated with occult malignancy.","volume":"69","author":"Hutchesson","year":"1993","journal-title":"Postgrad Med J"},{"key":"R78-2-20210202","first-page":"133","article-title":"Association of clear cell carcinoma of the endometrium with a high rate of venous thromboembolism.","volume":"54","author":"Lee","year":"2009","journal-title":"J Reprod Med"},{"key":"R79-2-20210202","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/1097-0142(197602)37:2<872::AID-CNCR2820370236>3.0.CO;2-L","article-title":"Clear cell carcinoma of the endometrium: an analysis of 21 cases.","volume":"37","author":"Kurman","year":"1976","journal-title":"Cancer"},{"key":"R80-2-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00125480-200405000-00001","article-title":"Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects.","volume":"11","author":"Clement","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"R81-2-20210202","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.semdp.2010.09.004","article-title":"Nonendometrioid endometrial carcinomas.","volume":"27","author":"Lim","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"R82-2-20210202","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/01.pas.0000213296.88778.db","article-title":"Precursors of endometrial clear cell carcinoma.","volume":"30","author":"Fadare","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R83-2-20210202","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/00313020601146822","article-title":"Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium.","volume":"39","author":"Lax","year":"2007","journal-title":"Pathology"},{"key":"R85-2-20210202","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7150\/jca.4140","article-title":"Does the loss of ARID1A (BAF-250a) expression in endometrial clear cell carcinomas have any clinicopathologic significance A pilot assessment.","volume":"3","author":"Fadare","year":"2012","journal-title":"J Cancer"},{"key":"R86-2-20210202","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/PAP.0b013e318234ab18","article-title":"Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.","volume":"18","author":"Bartosch","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"R87-2-20210202","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00000478-199206000-00008","article-title":"Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features.","volume":"16","author":"Sherman","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R88-2-20210202","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004347-200404000-00005","article-title":"Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium.","volume":"23","author":"Egan","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R89-2-20210202","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygyno.2009.09.029","article-title":"Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.","volume":"116","author":"Kobel","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R90-2-20210202","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00004347-199501000-00006","article-title":"Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.","volume":"14","author":"Carcangiu","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"R91-2-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200201000-00001","article-title":"Perivascular epithelioid cell tumor (PEComa) of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors.","volume":"26","author":"Vang","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R92-2-20210202","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00000478-200402000-00013","article-title":"Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa.","volume":"28","author":"Silva","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R93-2-20210202","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0b013e3181574d1e","article-title":"The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.","volume":"32","author":"Atkins","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R94-2-20210202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00000478-200204000-00001","article-title":"An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.","volume":"26","author":"Oliva","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R95-2-20210202","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM197104222841604","article-title":"Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women.","volume":"284","author":"Herbst","year":"1971","journal-title":"N Engl J Med"},{"key":"R96-2-20210202","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJM198702263160905","article-title":"Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.","volume":"316","author":"Melnick","year":"1987","journal-title":"N Engl J Med"},{"key":"R97-2-20210202","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9378(86)90464-3","article-title":"Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study.","volume":"154","author":"Herbst","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"R98-2-20210202","first-page":"404","article-title":"Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.","volume":"84","author":"Waggoner","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R100-2-20210202","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-9440(10)64619-6","article-title":"Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.","volume":"157","author":"Pirog","year":"2000","journal-title":"Am J Pathol"},{"key":"R101-2-20210202","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2229::AID-CNCR22>3.0.CO;2-X","article-title":"Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks.","volume":"79","author":"Hanselaar","year":"1997","journal-title":"Cancer"},{"key":"R102-2-20210202","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/gyno.1999.5471","article-title":"Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).","volume":"76","author":"Herbst","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R103-2-20210202","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/gyno.1999.5700","article-title":"Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol.","volume":"76","author":"Reich","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R104-2-20210202","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0002-9378(90)90840-4","article-title":"Clear cell carcinoma of the sigmoid mesocolon: a tumor of the secondary mullerian system.","volume":"162","author":"Evans","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"R105-2-20210202","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0090-8258(91)90320-5","article-title":"Primary clear cell carcinoma of the peritoneum.","volume":"41","author":"Lee","year":"1991","journal-title":"Gynecol Oncol"},{"key":"R106-2-20210202","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/01443619964526","article-title":"Clear cell adenocarcinoma of the peritoneum associated with clear cell adenocarcinoma arising in an endometrial polyp.","volume":"19","author":"Tziortzioti","year":"1999","journal-title":"J Obstet Gynaecol"},{"key":"R107-2-20210202","first-page":"1243","article-title":"Primary peritoneal clear cell carcinoma: excellent results from paclitaxel and carboplatin combination chemotherapy.","volume":"8","author":"Ichimura","year":"2001","journal-title":"Oncol Rep"},{"key":"R108-2-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1620\/tjem.206.271","article-title":"Primary clear cell adenocarcinoma of the peritoneum.","volume":"206","author":"Terada","year":"2005","journal-title":"Tohoku J Exp Med"},{"key":"R109-2-20210202","first-page":"575","article-title":"Primary clear cell carcinoma of the peritoneum: report of two cases and a review of the literature.","volume":"30","author":"Takano","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"R110-2-20210202","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10147-010-0052-y","article-title":"A case of diaphragmatic clear cell carcinoma in a patient with a medical history of ovarian endometriosis.","volume":"15","author":"Fujiu","year":"2010","journal-title":"Int J Clin Oncol"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00125480-201209000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T16:25:52Z","timestamp":1643991952000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00125480-201209000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0b013e31826663b1","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}